CERo Therapeutics Holdings, Inc. (OTC:CERO) IPO
IPO
Went public as PHOENIX BIOTECH ACQUISITION CORP., a blank check company (SPAC). Priced at US$10.00 a unit on Oct 5, 2021.
- Price
- US$10.00 a unit
- Units offered
- 15,500,000 units
- Offering size
- US$155 million
- Underwriters' option
- Up to 2,325,000 more units
- Underwriter
- Cantor
- Units delivered
- On or about Oct 8, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 8, 2021 |
| Filed publicly | Sep 13, 2021 |
| Amended twice | Newest Sep 28, 2021 |
| Shares registered with an exchange | Oct 5, 2021 |
| Declared effective by the SEC | Oct 5, 2021 |
| Final prospectus, with the price | Oct 8, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 8, 2021 |
| EFFECT · Notice that a registration is effective | Oct 5, 2021 |
| CERT · Exchange's certificate of listing | Oct 5, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 5, 2021 |
| CORRESP · Letter to the SEC | Oct 1, 2021 |
| CORRESP · Letter to the SEC | Oct 1, 2021 |
| S-1/A · Registration statement, amended | Sep 28, 2021 |
| S-1/A · Registration statement, amended | Sep 21, 2021 |
| S-1 · Registration statement | Sep 13, 2021 |
| UPLOAD · Letter from the SEC | Jul 27, 2021 |
| DRS · Draft registration statement | Jul 8, 2021 |
From the cover of the final prospectus (424B4) filed Oct 8, 2021